Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Retrospective Evaluation of Cycled Resin in Viral Clearance Studies—A Multiple Company Collaboration

John Mattila, Sherrie Curtis, Yenny Webb-Vargas, Eileen Wilson, Olga Galperina, David Roush, Scott Tobler, Bradford Stanley, Mike Clark, Justin Weaver, Jeremy Pike, Deqiang Yu, Xinfang Li, Andreas Flicker, Johanna Kindermann, Norbert Schuelke, Richard Whitcombe and Louise Bennett
PDA Journal of Pharmaceutical Science and Technology September 2019, 73 (5) 470-486; DOI: https://doi.org/10.5731/pdajpst.2018.009605
John Mattila
1Regeneron Pharmaceuticals Inc., Tarrytown, NY;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherrie Curtis
2Genentech, Inc., South San Francisco, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yenny Webb-Vargas
2Genentech, Inc., South San Francisco, CA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eileen Wilson
3GlaxoSmithKline plc, King of Prussia, PA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Galperina
4GlaxoSmithKline plc, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Roush
5Merck & Co., Inc., Kenilworth, NJ, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Tobler
5Merck & Co., Inc., Kenilworth, NJ, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradford Stanley
6Biogen, Research Triangle Park, NC;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Clark
7AbbVie Bioresearch Center, Worcester, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Weaver
8Alexion Pharmaceuticals, Inc. Boston, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Pike
8Alexion Pharmaceuticals, Inc. Boston, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deqiang Yu
9Bristol-Myers Squibb, Devens MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinfang Li
10ImmunoGen, Inc. Waltham, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Flicker
11Shire plc, Lexington, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Kindermann
11Shire plc, Lexington, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Schuelke
12Takeda Pharmaceuticals International Co., Cambridge, MA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Whitcombe
13UCB, Brussels, Belgium; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Bennett
14BioPhorum Operations Group, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bennettl@biophorum.com
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Anderson K. P.,
    2. Low M.-A. L.,
    3. Lie Y. S.,
    4. Keller G.-A.,
    5. Dinowitz M.
    Endogenous Origin of Defective Retrovirus-Like Particles from a Recombinant Chinese Hamster Ovary Cell Line. Virology 1991, 181 (1), 305–311.
    OpenUrlPubMed
  2. 2.↵
    1. Garnick R. L.
    Raw Materials as a Source of Contamination in Large Scale Cell Culture. Dev. Biol. Stand. 1998, 93, 21–29.
    OpenUrlPubMedWeb of Science
  3. 3.↵
    1. Nims R. W.
    Detection of Adventitious Viruses in Biologicals – a Rare Occurrence. Dev. Biol. 2006, 123, 153–164.
    OpenUrl
  4. 4.↵
    European Medicines Agency, Guideline on Virus Safety Evaluation of Biotechnology Investigational Medicinal Products. EMA: London, 2008.
  5. 5.↵
    European Agency for the Evaluation of Medicinal Products, Note for Guidance on Virus Validation Studies: The Design, Contribution and Interpretation of Studies Validating the Inactivation and Removal of Viruses; CPMP/BWP/268/95; Committee for Proprietary Medicinal Products; EMA: London, 1996.
  6. 6.↵
    U.S. Food and Drug Administration, Points to Consider in the Manufacture and Testing of Monoclonal Antibodies for Human Use; Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services: Rockville, MD, 1997.
  7. 7.↵
    International Conference for Harmonisation, Quality Guideline Q5A: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. ICH: Geneva, Switzerland, 1998.
  8. 8.↵
    1. Blümel J.,
    2. Brorson K.
    Session 2: Company-Specific Data on Cycled Resin Testing. PDA J. Pharm. Sci. Technol. 2016, 70 (5), 428–442.
    OpenUrlFREE Full Text
  9. 9.↵
    1. Brorson K.,
    2. Brown J.,
    3. Hamilton E.,
    4. Stein K. E.
    Identification of Protein a Media Performance Attributes That Can Be Monitored as Surrogates for Retrovirus Clearance during Extended Re-Use. J. Chromatogr. A 2003, 989 (1), 155–163.
    OpenUrlPubMed
  10. 10.↵
    European Medicines Agency, Meeting Report: Joint BWP/QWP Workshop with Stakeholders in Relation to Prior Knowledge and Its Use in Regulatory Applications; Doc. Ref. EMA/CHMP/BWP/187162/2018; EMA: London, 2018.
  11. 11.↵
    1. Lute S.,
    2. Norling L.,
    3. Hanson M.,
    4. Emery R.,
    5. Stinson D.,
    6. Padua K.,
    7. Blank G.,
    8. Chen Q.,
    9. Brorson K.
    Robustness of Virus Removal by Protein a Chromatography Is Independent of Media Life Time. J. Chromatogr. A 2008, 1205 (1–2), 17–25.
    OpenUrlPubMed
  12. 12.↵
    1. Kelley B. D.,
    2. Jakubik J.,
    3. Vicik S.
    Viral Clearance Studies on New and Used Chromatography Resins: Critical Review of a Large Dataset. Biologicals 2008, 36 (2), 88–98.
    OpenUrlPubMed
  13. 13.↵
    1. Norling L.,
    2. Lute S.,
    3. Emery R.,
    4. Khuu W.,
    5. Voisard M.,
    6. Xu Y.,
    7. Chen Q.,
    8. Blank G.,
    9. Brorson K.
    Impact of Multiple Re-Use of Anion-Exchange Chromatography Media on Virus Removal. J. Chromatogr. A 2005, 1069 (1), 79–89.
    OpenUrlPubMed
  14. 14.↵
    1. Roush D.
    Viral Clearance Using Traditional, Well-Understood Unit Operations: Session 1.2. Anion Exchange Chromatography; and Session 1.3. Protein a Chromatography. PDA J. Pharm. Sci. Technol. 2015, 69 (1), 154–162.
    OpenUrlFREE Full Text
  15. 15.↵
    1. Miesegaes G.,
    2. Lute S.,
    3. Brorson K.
    Analysis of Viral Clearance Unit Operations for Monoclonal Antibodies. Biotechnol. Bioeng. 2010, 106 (2), 238–246.
    OpenUrlPubMed
  16. 16.↵
    1. Zhang M.,
    2. Lute S.,
    3. Norling L.,
    4. Hong C.,
    5. Safta A.,
    6. O'Connor D.,
    7. Bernstein L. J.,
    8. Wang H.,
    9. Blank G.,
    10. Brorson K.,
    11. Chen Q.
    A Novel, Q-PCR Based Approach to Measuring Endogenous Retroviral Clearance by Capture Protein a Chromatography. Biotechnol. Bioeng. 2009, 102 (5), 1438–1447.
    OpenUrlPubMed
  17. 17.↵
    1. Zhang M.,
    2. Miesegaes G. R.,
    3. Lee M.,
    4. Coleman D.,
    5. Yang B.,
    6. Trexler-Schmidt M.,
    7. Norling L.,
    8. Lester P.,
    9. Brorson K. A.,
    10. Chen Q.
    Quality by Design Approach for Viral Clearance by Protein A Chromatography. Biotechnol. Bioeng. 2014, 111 (1), 95–103.
    OpenUrl
  18. 18.↵
    1. Bach J.,
    2. Connell-Crowley L.
    Clearance of the Rodent Retrovirus, XMuLV, by Protein A Chromatography. Biotechnol. Bioeng. 2015, 112 (4), 743–750.
    OpenUrl
  19. 19.↵
    1. Strauss D. M.,
    2. Lute S.,
    3. Tebaykina Z.,
    4. Frey D. D.,
    5. Ho C.,
    6. Blank G. S.,
    7. Brorson K.,
    8. Chen Q.,
    9. Yang B.
    Understanding the Mechanism of Virus Removal by Q Sepharose Fast Flow Chromatography during the Purification of CHO-Cell Derived Biotherapeutics. Biotechnol. Bioeng. 2009, 104 (2), 371–380.
    OpenUrlPubMed
  20. 20.↵
    1. Strauss D. M.,
    2. Gorrell J.,
    3. Plancarte M.,
    4. Blank G. S.,
    5. Chen Q.,
    6. Yang B.
    Anion Exchange Chromatography Provides a Robust, Predictable Process to Ensure Viral Safety of Biotechnology Products. Biotechnol. Bioeng. 2009, 102 (1), 168–175.
    OpenUrlPubMed
  21. 21.↵
    U.S. Pharmacopeial Convention, General Chapter <1050.1> Viral Clearance Procedures. In USP 39–NF 34, USP: Rockville, MD, 2016; pp 7745–7755.
  22. 22.↵
    Parenteral Drug Association Inc. Preparation of Virus Spikes Used for Viral Clearance Studies; Technical Report No. 47; PDA: Bethesda, MD, 2010.
  23. 23.
    1. Nicola A. V.,
    2. Peng C.,
    3. Lou H.,
    4. Cohen G. H.,
    5. Eisenberg R. J.
    Antigenic Structure of Soluble Herpes Simplex Virus (HSV) Glycoprotein D Correlates with Inhibition of HSV Infection. J. Virol. 1997, 71 (4), 2940–2946.
    OpenUrlAbstract/FREE Full Text
  24. 24.
    1. Taylor D. H.,
    2. Bosmann H. B.
    Measurement of the Electrokinetic Properties of Vaccinia and Reovirus by Laser Illuminated Whole-Particle Microelectrophoresis. J. Virol. Methods 1981, 2 (5), 251–260.
    OpenUrlPubMed
  25. 25.
    1. Venkatakrishnan B.,
    2. Yarbrough J.,
    3. Domsic J.,
    4. Bennett A.,
    5. Bothner B.,
    6. Kozyreva O. G.,
    7. Samulski R. J.,
    8. Muzyczka N.,
    9. McKenna R.,
    10. Agbandje-McKenna M.
    Structure and Dynamics of Adeno-Associated Virus Serotype 1 VP1- Unique N-Terminal Domain and Its Role in Capsid Trafficking. J. Virol. 2013, 87 (9), 4974–4984.
    OpenUrlAbstract/FREE Full Text
  26. 26.
    1. Seabrook E. J.,
    2. Turton T. N.,
    3. Conlan B.
    Factor VIII Separation. U.S. Patent 7,144,487, Dec 5, 2006.
  27. 27.
    1. Michen B.,
    2. Graule T.
    Isoelectric Points of Viruses. J Appl Microbiol 2010, 109 (2), 388–397.
    OpenUrlCrossRefPubMed
  28. 28.
    1. Walsh A. A.
    Charge Differences Between AMuLV and XMuLV Measured Through Viral Clearance Using Anion Exchange Chromatography. Thesis, Villanova University, 2016.
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 73 (5)
PDA Journal of Pharmaceutical Science and Technology
Vol. 73, Issue 5
September/October 2019
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Retrospective Evaluation of Cycled Resin in Viral Clearance Studies—A Multiple Company Collaboration
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
15 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Retrospective Evaluation of Cycled Resin in Viral Clearance Studies—A Multiple Company Collaboration
John Mattila, Sherrie Curtis, Yenny Webb-Vargas, Eileen Wilson, Olga Galperina, David Roush, Scott Tobler, Bradford Stanley, Mike Clark, Justin Weaver, Jeremy Pike, Deqiang Yu, Xinfang Li, Andreas Flicker, Johanna Kindermann, Norbert Schuelke, Richard Whitcombe, Louise Bennett
PDA Journal of Pharmaceutical Science and Technology Sep 2019, 73 (5) 470-486; DOI: 10.5731/pdajpst.2018.009605

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Retrospective Evaluation of Cycled Resin in Viral Clearance Studies—A Multiple Company Collaboration
John Mattila, Sherrie Curtis, Yenny Webb-Vargas, Eileen Wilson, Olga Galperina, David Roush, Scott Tobler, Bradford Stanley, Mike Clark, Justin Weaver, Jeremy Pike, Deqiang Yu, Xinfang Li, Andreas Flicker, Johanna Kindermann, Norbert Schuelke, Richard Whitcombe, Louise Bennett
PDA Journal of Pharmaceutical Science and Technology Sep 2019, 73 (5) 470-486; DOI: 10.5731/pdajpst.2018.009605
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion and Recommendations
    • Conflict of Interest Declaration
    • Acknowledgements
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Proceedings of the 2023 Viral Clearance Symposium: 2023 VCS Summary, Pending Questions, and Next Steps
  • Proceedings of the 2019 Viral Clearance Symposium, Session 4: Viral Clearance Strategy and Process Understanding
  • Google Scholar

More in this TOC Section

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
  • Evaluation of Extreme Depyrogenation Conditions on the Surface Hydrolytic Resistance of Glass Containers for Pharmaceutical Use
  • A Holistic Approach for Filling Volume Variability Evaluation and Control with Statistical Tool
Show more Research

Similar Articles

Keywords

  • Viral clearance
  • packed bed chromatography
  • Resin reuse
  • Protein A
  • anion exchange

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire